Cargando...
Triple Reuptake Inhibitors: A Premise and Promise
On the horizon there is a new class of psychoactive medications which work by inhibiting the neuronal reuptake of serotonin, norepinephrine, and dopamine. There are multiple potential indications for these drugs. Research suggests that they may have a role in treating depressive disorders, and it is...
Gardado en:
| Main Authors: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Korean Neuropsychiatric Association
2008
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2796030/ https://ncbi.nlm.nih.gov/pubmed/20046357 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4306/pi.2008.5.3.142 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|